Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	53.03	-13.06	-27.80
Graham Fair Price	41.38	0.97	0.69
PEG	96.96	< 0.005	-0.17
Price/Book	-27.43	0.24	0.34
Price/Cash Flow	-75.96	-9.04	37.61
Prices/Earnings	63.71	-0.53	-1.46
Price/Sales	-63.59	1.33	3.64
Price/FCF	-75.96	-9.04	37.61
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-9.34	-0.04	-0.04
Operating Margin	0.94	-0.65	-0.65
ROA	-100.00	-0.03	-0.02
ROE	-0.06	-0.11	-100.00
ROIC	-0.04	-0.05	-47.23
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	< 0.005	-70.11
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.99	-0.97	1.48
EPS QOQ	-0.08	-1.00	-1092.31
FCF QOQ	1.21	-4.02	231.99
Revenue QOQ	-0.66	0.99	49.35
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	69.03	34.51	-50.00
Days Sales Outstanding (DSO)	928.69	536.93	-42.18
Inventory Turnover	1.30	2.61	100.00
Debt/Capitalization	0.48	0.48	-0.03
Quick Ratio	0.64	0.75	16.37
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.61	0.61	-0.03
Cash	< 0.005	0.02	96.14
Capex	< 0.005	< 0.005	-11.32
Free Cash Flow	< 0.005	-0.02	201.73
Revenue	0.06	0.11	99.24
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.82	0.82	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-20.33	-10.28	49.43
Naive Interpretation	Member

06 - Financial Health · Bad

Rating